Mandatory notice of trade in IDEX

IDEX ASA issues this notice on behalf of Vice President of Strategy and Sales Kristian Wiermyhr who is a primary insider in the company.

Mr. Wiermyhr holds 3,000,000 incentive subscription rights to shares in IDEX ASA, which subscription rights were granted on 30 August 2012. The subscription rights originally vested 2012-2014 and were to expire on 30 August 2014. IDEX and Mr. Wiermyhr have agreed that the expiry date shall be deferred until 15 May 2017, and the vesting shall be 25% at each anniversary from the original grant date.

The foregoing amendment of terms does not change Mr. Wiermyhr and his close relation’s holding of shares or rights to shares in IDEX ASA, which remains 3,762,235 shares and 3,000,000 rights to shares.

18 June 2014
IDEX ASA

Web: www.idexbiometrics.com 
Twitter: http://www.twitter.com/idexasa
LinkedIn: http://www.linkedin.com/company/idex-asa 

Contact:
Erling Svela, acting CFO,  +47 4062 1040,  erling.svela(at)idexbiometrics.com

About IDEX
IDEX ASA specialises in fingerprint imaging and recognition technology. IDEX’s vision is to ensure individuals a safe, secure, and user-friendly use of personal ID. IDEX has developed the award-winning SmartFinger technology platform based on the company’s core intellectual property, including the patented fingerprint imaging principle, sensing scheme and chip design. Combined with core software solutions for imaging and authentication, the SmartFinger technology enables on-device enrollment, template storage and verification within the very same module. SmartFinger solutions can be seamlessly integrated into a variety of embedded applications such as mobile phones, one-time password devices, Smartcards, payment and ID cards, payment terminals, access control devices and biometric security and login tokens.

IDEX ASA (ticker IDEX) is a Norwegian public company listed at the Oslo Axess marketplace on the Oslo Børs (Oslo stock exchange). For more information, please visit www.idexbiometrics.com or contact IDEX at mailbox@idexbiometrics.com
–o–

 
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

FACEBOOK
GOOGLE
TWITTER
LINKEDIN